EX-31.4 3 ampe-20221231xex31d4.htm EX-31.4

EXHIBIT 31.4

CERTIFICATION

I, Daniel G. Stokely, certify that:

1.  I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Ampio Pharmaceuticals, Inc. for the year ended December 31, 2022; and

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

/s/ Daniel G. Stokely

 

Daniel G. Stokely

 

Chief Financial Officer

 

 

Date: April 28, 2023